Circulation: Arrhythmia and Electrophysiology

DECEMBER 21, 2023

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Inflammation may promote atrial fibrillation (AF) recurrence after catheter ablation. The first dose of the study drug was administered within 4 hours before ablation. mg twice daily or placebo for 10 days. mg twice daily or placebo for 10 days.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Chest Pain Atrial Flutter 40

Journal of Cardiovascular Electrophysiology

JANUARY 15, 2024

Abstract Introduction Atrial fibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrial tachycardia 6 months post heart transplant. This arrhythmia was successfully terminated with radiofrequency ablation.

Atrial Fibrillation 40

Atrial Fibrillation Heart Transplant Atrial Flutter Transplant 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

FAAM ablation successfully decreased the recurrence rate of atrial tachyarrhythmia compared with conventional non-PV foci ablation. Abstract Introduction Treatment of recurrent atrial fibrillation (AF) is sometimes challenging due to non-pulmonary vein (PV) foci. The RHYTHMIA system was used to perform all the procedures.

Ablation 40

Ablation Atrial Fibrillation Atrial Flutter Tachycardia 40

Journal of Cardiovascular Electrophysiology

OCTOBER 19, 2023

Abstract The QDOT MICRO™ Catheter is a novel open-irrigated contact force-sensing radiofrequency ablation catheter. It offers very high-power short-duration (vHPSD) ablation with 90 W for 4 s to improve safety and efficacy of catheter ablation procedures.

Arrhythmia 40

Arrhythmia Ablation Atrial Flutter Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

Abstract Background Dofetilide is a class III antiarrhythmic agent approved for the treatment of atrial fibrillation and atrial flutter. Prior catheter ablation had been performed in 33 patients (41%). A80% decrease in PVC burden was defined as a satisfactory response. An ICD was present in 72 patients (89%).

Tachycardia 40

Tachycardia Heart Disease Atrial Flutter Heart Transplant 40

Dr. Smith's ECG Blog

SEPTEMBER 7, 2020

The Differential Diagnosis is: SVT with aberrancy(#) [AVNRT vs. WPW (also called AVRT*)] Atrial flutter with 1:1 conduction, with aberrancy VT coming from the anterior fascicle ( fascicular VT )@ *AVRT = AV Reciprocating Tachycardia (Tachycardic loop that uses both the AV node and an accessory pathway.

Tachycardia 52

Tachycardia Heart Disease Ablation Dysrhythmia 52

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA).

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

Journal of Cardiovascular Electrophysiology

DECEMBER 16, 2024

ABSTRACT Introduction The safety and efficacy of paroxysmal atrial fibrillation (PAF) ablation with the HELIOSTAR multielectrode radiofrequency (RF) balloon catheter have been demonstrated in European studies; data from elsewhere are lacking. Image is courtesy of Biosense Webster, Inc., part of Johnson & Johnson MedTech.

Atrial Fibrillation 40

Atrial Fibrillation Quality of Life Atrial Flutter Ablation 40

Frontiers in Cardiovascular Medicine

NOVEMBER 14, 2024

IntroductionThe precise pathophysiology of common atrial flutter remains imperfectly known. No conduction slowing is present.ConclusionsCommon atrial flutter initiates when functional unidirectional conduction block occurs on the septal cavotricuspid isthmus.

Electrophysiology 59

Electrophysiology Atrial Flutter Tricuspid Arrhythmia 59

Journal of Cardiovascular Electrophysiology

JANUARY 7, 2025

ABSTRACT Typical atrial flutter (AFL), defined as cavotricuspid isthmus (CTI)-dependent macro-re-entrant atrial tachycardia, often causes debilitating symptoms, and is associated with increased incidence of atrial fibrillation, stroke, heart failure, and death.

Atrial Flutter 45

Atrial Flutter Atrial Fibrillation Quality of Life Ablation 45

DAIC

OCTOBER 30, 2024

The PulseSelect Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation (PVI) while the Affera Sphere-9 catheter enables physician treatment flexibility with its wide area focal design and 9mm lattice tip that can used with an 8.5Fr sheath.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52

Journal of Cardiovascular Electrophysiology

JANUARY 27, 2025

ABSTRACT Introduction Freedom from recurrences of atrial tachyarrhythmia (ATA) is suboptimal after pulmonary vein isolation (PVI) in patients with persistent atrial fibrillation (PsAF). Univariate and multivariable Cox regression analysis (with ATA recurrence as an endpoint) was performed to identify CBA responders. years old (69.2%

Atrial Fibrillation 40

Atrial Fibrillation Ablation Atrial Flutter Arrhythmia 40